IP vs MGRX · P/E 43, $26.62B cap vs rev $615.9K
International Paper (IP) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported MGRX revenue for 2024-12-31 was $615.9K. Net income was -$8.7M. Revenue was down 15.8% from 2023-12-31 to 2024-12-31. MGRX currently screens at market cap $16.3M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the IP and MGRX stock pages for the full models.
Not investment advice.